Home > Products > Pharmaceuticals & Life Science > Pharmaceutical Intermediates > (R)-N-(1-(7-(but-2-yn-1-yl)-3-methyl-1-((4-methylquinazolin-2-yl)methyl)-2,6-dioxo-2,3,6,7-tetrahydro-1H-purin-8-yl)piperidin-3-yl)acetamide
(R)-N-(1-(7-(but-2-yn-1-yl)-3-methyl-1-((4-methylquinazolin-2-yl)methyl)-2,6-dioxo-2,3,6,7-tetrahydro-1H-purin-8-yl)piperidin-3-yl)acetamide structure, CAS 2A-1168488

(R)-N-(1-(7-(but-2-yn-1-yl)-3-methyl-1-((4-methylquinazolin-2-yl)methyl)-2,6-dioxo-2,3,6,7-tetrahydro-1H-purin-8-yl)piperidin-3-yl)acetamide

CAS Number2A-1168488

Synonyms

Molecular FormulaC27H30N8O3

Molecular Weight514.5858

Purity

Density

Boiling Point

Melting Point

Flash Point

Appearance

EINECS

MSDSChineseEnglish

Symbol

Signal Word

Cat. No.: 2A-1168488 Purity:
Change View

Please Login or Create an Account to: See VlP prices and availability

US Stock: ship in 0-1 business day
Global Stock: ship in 5-7 days

Quality Control of [ 2A-1168488 ] SDS Specification MoL

Chemical & Physical Properties
CAS Number2A-1168488
Catalog No.2A-1168488
Molecular FormulaC27H30N8O3
Molecular Weight514.5858
PubChem ID318389051
SMILESCC#CCn1c(nc2N(C)C(=O)N(Cc3nc(C)c4ccccc4n3)C(=O)c12)N5CCC[C@H](C5)NC(C)=O
InChIInChI=1S/C27H30N8O3/c1-5-6-14-34-23-24(31-26(34)33-13-9-10-19(15-33)29-18(3)36)32(4)27(38)35(25(23)37)16-22-28-17(2)20-11-7-8-12-21(20)30-22/h7-8,11-12,19H,9-10,13-16H2,1-4H3,(H,29,36)/t19-/m1/s1
InChI KeyInChIKey=KWOITPIVEAFNPU-LJQANCHMSA-N
Related Products in Pharmaceutical Intermediates
(3S,8R,9S,10R,13S,14S)-10,13-dimethyl-7-oxo-17-(pyridin-3-yl)-2,3,4,7,8,9,10,11,12,13,14,15-dodecahydro-1H-cyclopenta[a]phenanthren-3-yl acetate2A-11684772A-1168477
(4S,6aR,6bS,8aS,8bR,9aR,10aS,10bR)-6a,8a-dimethyl-8b-(pyridin-3-yl)-3,4,5,6,6a,6b,7,8,8a,8b,9a,10,10a,10b-tetradecahydro-1H-naphtho[2',1':4,5]indeno[1,2-b]oxiren-4-yl acetate;17-(Pyridin-3-yl)-16β,17β-epoxyandrost-5-en-3β-yl acetate2A-11684802A-1168480
(4S,6aR,6bS,8aS,8bS,9aS,10aS,10bR)-6a,8a-dimethyl-8b-(pyridin-3-yl)-3,4,5,6,6a,6b,7,8,8a,8b,9a,10,10a,10b-tetradcahydro-1H-naphtho[2',1':4,5]indeno[1,2-b]oxiren-4-yl cetate;17-(Pyridin-3-yl)-16α,17α-epoxyandrost-5-en-3β-yl cetate2A-11684812A-1168481
(R)-2-(benzyl(2-hydroxy-1-phenylethyl)amino)acetonitrile2A-11684862A-1168486
(R)-7-(but-2-yn-1-yl)-8-(3-((7-(but-2-yn-1-yl)-3-methyl-1-((4-methylquinazolin-2-yl)methyl)-2,6-dioxo-2,3,6,7-tetrahydro-1H-purin-8-yl)amino)piperidin-1-yl)-3-methyl-1-((4-methylquinazolin-2-yl)methyl)-1H-purine-2,6(3H,7H)-dione2A-11684872A-1168487
(R)-N-[1-(Naphthalen-1-yl)ethyl]-3-[3-(trifluoromethyl)phenyl]-N-{3-[3-(trifluoromethyl)phenyl]propyl}propan-1-amine1271930-15-42A-1168489
(R)-tetrahydrofuran-3-yl 124506-31-62A-1168490
1-(tert-butyl) 2-methyl (2R,5R)-5-(4-((2-fluorobenzyl)oxy)phenyl)pyrrolidine-1,2-dicarboxylate2A-11684912A-1168491
1-(tert-butyl) 2-methyl (2R,5R)-5-(4-((phenylsulfinyl)oxy)phenyl)pyrrolidine-1,2-dicarboxylate2A-11684922A-1168492
1-(tert-butyl) 2-methyl (2R,5R)-5-(4-(benzyloxy)phenyl)pyrrolidine-1,2-dicarboxylate2A-11684932A-1168493
Browse all Pharmaceutical Intermediates products »
Contact Us

Phone:

630-322-8886

630-322-8887

Email:

[email protected]

Office Locations:

Chicago, IL, USA

San Francisco, CA, USA